Literature DB >> 21576380

Analysis of functional responses at G protein-coupled receptors: estimation of relative affinity constants for the inactive receptor state.

Frederick J Ehlert1, Michael T Griffin, Hinako Suga.   

Abstract

We describe a modification of receptor theory that enables the estimation of relative affinity constants for the inactive state of a G protein-coupled receptor. Our approach includes the traditional parameters of observed affinity (K(obs)) and efficacy (fraction of ligand-receptor complex in the active state, ε) and introduces the concept of the fraction of the ligand-receptor complex in the inactive state (intrinsic inactivity, ε(i)). The relationship between receptor activation and the ligand concentration is known as the stimulus, and the operational model expresses the response as a logistic function of the stimulus. The latter function includes K(obs) and the parameter τ, which is proportional to ε. We introduce the parameter τ(i), which is proportional to ε(i). We have previously shown that the product, K(obs)τ, of one agonist, expressed relative to that of another (intrinsic relative activity, RA(i)), is a relative measure of the affinity constant for the active state of the receptor. In this report, we show that the product, K(obs)τ(i), of one agonist, expressed relative to that of another (intrinsic relative inactivity, RI(i)), is a relative measure of the affinity constant for the inactive state of the receptor. We use computer simulation techniques to verify our analysis and apply our method to the analysis of published data on agonist activity at the M(3) muscarinic receptor. Our method should have widespread application in the analysis of agonist bias in drug discovery programs and in the estimation of a more fundamental relative measure of efficacy (RA(i)/RI(i)).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576380      PMCID: PMC3141892          DOI: 10.1124/jpet.111.179291

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells.

Authors:  F J Ehlert; M T Griffin; G W Sawyer; R Bailon
Journal:  J Pharmacol Exp Ther       Date:  1999-05       Impact factor: 4.030

2.  A modification of receptor theory.

Authors:  R P STEPHENSON
Journal:  Br J Pharmacol Chemother       Date:  1956-12

3.  Functional selectivity and biased receptor signaling.

Authors:  Terry Kenakin
Journal:  J Pharmacol Exp Ther       Date:  2010-10-28       Impact factor: 4.030

Review 4.  Heterotrimeric G protein activation by G-protein-coupled receptors.

Authors:  William M Oldham; Heidi E Hamm
Journal:  Nat Rev Mol Cell Biol       Date:  2008-01       Impact factor: 94.444

5.  Signaling through the muscarinic receptor-adenylate cyclase system of the heart is buffered against GTP over a range of concentrations.

Authors:  F J Ehlert; B E Rathbun
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

6.  Operational models of pharmacological agonism.

Authors:  J W Black; P Leff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-12-22

7.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor.

Authors:  A De Lean; J M Stadel; R J Lefkowitz
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

8.  Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors.

Authors:  John A Tran; Alexander Chang; Minoru Matsui; Frederick J Ehlert
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

9.  Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate.

Authors:  D Colquhoun; B Sakmann
Journal:  J Physiol       Date:  1985-12       Impact factor: 5.182

Review 10.  On the analysis of ligand-directed signaling at G protein-coupled receptors.

Authors:  Frederick J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-06       Impact factor: 3.000

View more
  7 in total

1.  Analysis of agonism and inverse agonism in functional assays with constitutive activity: estimation of orthosteric ligand affinity constants for active and inactive receptor states.

Authors:  Frederick J Ehlert; Hinako Suga; Michael T Griffin
Journal:  J Pharmacol Exp Ther       Date:  2011-05-16       Impact factor: 4.030

Review 2.  Efficacy and ligand bias at the μ-opioid receptor.

Authors:  E Kelly
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

3.  A method for the quantification of biased signalling at constitutively active receptors.

Authors:  David A Hall; Jesús Giraldo
Journal:  Br J Pharmacol       Date:  2018-04-25       Impact factor: 8.739

Review 4.  Functional studies cast light on receptor states.

Authors:  Frederick J Ehlert
Journal:  Trends Pharmacol Sci       Date:  2015-06-26       Impact factor: 14.819

5.  Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptors.

Authors:  Kelly M DiMattio; Frederick J Ehlert; Lee-Yuan Liu-Chen
Journal:  Eur J Pharmacol       Date:  2015-06-06       Impact factor: 4.432

6.  Estimation of the receptor-state affinity constants of ligands in functional studies using wild type and constitutively active mutant receptors: Implications for estimation of agonist bias.

Authors:  Frederick J Ehlert; Richard S L Stein
Journal:  J Pharmacol Toxicol Methods       Date:  2016-10-07       Impact factor: 1.950

7.  Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias.

Authors:  Frederick J Ehlert; Michael T Griffin
Journal:  J Pharmacol Toxicol Methods       Date:  2014-01-13       Impact factor: 1.950

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.